A Multicenter, Double-blind, Randomized, Placebo-controlled Trial of the β3-Adrenoceptor Agonist Solabegron for Overactive Bladder
Eliot H. Ohlstein, Alexander von Keitz, Martin C. MichelVolume:
62
Year:
2012
Language:
english
DOI:
10.1016/j.eururo.2012.05.053
File:
PDF, 490 KB
english, 2012